» Articles » PMID: 35565300

Characterization of the Peri-Membrane Fluorescence Phenomenon Allowing the Detection of Urothelial Tumor Cells in Urine

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 May 14
PMID 35565300
Authors
Affiliations
Soon will be listed here.
Abstract

Urine cytology is non-invasive, easy to collect, with medium sensitivity and a high specificity. It is an effective way to detect high-grade bladder cancer (BC), but it is less effective on low-grade BC because the rate of equivocal results is much higher. Recently, the fluorescent properties of plasma membranes of urothelial tumor cells (UTC) found in urine cytology have been shown to be useful in improving the early detection of BC. This phenomenon is called peri-membrane fluorescence (PMF). Based on previous studies that have identified the PMF on UTCs, the main objective was to characterize this phenomenon. For this study, a software was specially created to quantify the PMF of all tested cells and different treatments performed. PMF was not found to be a morphological and discriminating feature of UTCs, all cells in shape and not from urine show PMF. We were able to highlight the crucial role of plasma membrane integrity in the maintenance of PMF. Finally, it was found that the induction of a strong cellular stress induced a decrease in PMF, mimicking what was observed in non-tumor cells collected from urine. These results suggest that PMF is found in cells able to resist this stress, such as tumor cells.

Citing Articles

Insights into Urologic Cancer.

Klumper N, Ellinger J Cancers (Basel). 2023; 15(12).

PMID: 37370718 PMC: 10295856. DOI: 10.3390/cancers15123108.

References
1.
Paoli P, Giannoni E, Chiarugi P . Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833(12):3481-3498. DOI: 10.1016/j.bbamcr.2013.06.026. View

2.
Furse S, de Kroon A . Phosphatidylcholine's functions beyond that of a membrane brick. Mol Membr Biol. 2015; 32(4):117-9. DOI: 10.3109/09687688.2015.1066894. View

3.
Miyanaga N, Akaza H, Tsukamoto T, Ishikawa S, Noguchi R, Ohtani M . Urinary nuclear matrix protein 22 as a new marker for the screening of urothelial cancer in patients with microscopic hematuria. Int J Urol. 1999; 6(4):173-7. DOI: 10.1046/j.1442-2042.1999.06437.x. View

4.
Birko Z, Nagy B, Klekner A, Virga J . Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy. Int J Mol Sci. 2020; 21(20). PMC: 7589793. DOI: 10.3390/ijms21207522. View

5.
Karpinich N, Tafani M, Rothman R, Russo M, Farber J . The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem. 2002; 277(19):16547-52. DOI: 10.1074/jbc.M110629200. View